Internal Server Error

Bio Longevity Labs - About the company

Bio Longevity Labs is an unfunded company based in Austin (United States), founded in 2024. It operates as a Manufacturer of research peptides and bioregulators. Bio Longevity Labs has not raised any funding yet. The company has 67 active competitors, including 7 funded and 10 that have exited. Its top competitors include companies like AmbioPharm, Enzene and PolyPeptide.

Company Details

Manufacturer of research peptides and bioregulators. It produces peptides and bioregulators for research and development purposes. The manufacturing process adheres to Good Manufacturing Practices (GMP), utilizing advanced techniques for synthesis, cleavage, and purification. Third-party testing ensures purity and safety. Products are sold directly to researchers and health professionals.
Key Metrics
Founded Year
2024
Location
Austin, United States
Stage
Unfunded
Ranked
Similar Companies
Sign up to download Bio Longevity Labs' company profile

Bio Longevity Labs's funding and investors

Bio Longevity Labs has not raised any funding rounds yet.

chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Bio Longevity Labs's Competitors and alternates

Top competitors of Bio Longevity Labs include AmbioPharm, Enzene and PolyPeptide. Here is the list of Top 10 competitors of Bio Longevity Labs, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for AmbioPharm
AmbioPharm
2006, North Augusta (United States), Acquired
Peptide manufacturing and development services, setting a new standard worldwide
$24M
58/100
2nd
Logo for Enzene
Enzene
2015, Pune (India), Series C
Company specializing in development of Biosimilars
$50M
55/100
3rd
Logo for PolyPeptide
PolyPeptide
1952, Baar (Switzerland), Public
CMO manufacturing proprietary,GMP grade and non-GMP-grade peptides
-
-
48/100
4th
Provider of drug research and development services focused on cardiovascular and metabolic diseases
$72.2M
45/100
5th
Logo for Hybio Pharmaceutical
Hybio Pharmaceutical
1998, Shenzhen (China), Public
Developer and manufacturer of polypeptide drugs and APis
$15M
43/100
6th
Logo for JPT Peptide
JPT Peptide
2004, Berlin (Germany), Acquired
Peptide based CRO offering proteomics, biomarker and drug discovery services
-
-
41/100
7th
Logo for Custom Peptide Synthesis
Custom Peptide Synthesis
2011, Mumbai (India), Unfunded
Manufacturer of peptides and other finished formulations, & APIs
-
-
40/100
8th
Logo for Proteos Biotech
Proteos Biotech
2010, Madrid (Spain), Unfunded
Manufacturer of recombinant enzymes and provides CMO services
-
-
38/100
9th
Logo for Rameda
Rameda
1994, Giza (Egypt), Public
Developer and manufacturer of generic pharmaceuticals, nutraceuticals, food supplements and veterinary products
-
37/100
10th
Logo for USV Peptides
USV Peptides
2011, Mumbai (India), Unfunded
CDMO offering custom peptide, GMP peptide and cosmetic peptide synthesis services
-
-
34/100
54th
Logo for Bio Longevity Labs
Bio Longevity Labs
2024, Austin (United States), Unfunded
Manufacturer of research peptides and bioregulators
-
-
16/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Bio Longevity Labs's competitors? Click here to see the top ones

Bio Longevity Labs's Investments and acquisitions

Bio Longevity Labs has made no investments or acquisitions yet.

Reports related to Bio Longevity Labs

Here is the latest report on Bio Longevity Labs's geography:

News related to Bio Longevity Labs

lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Bio Longevity Labs

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford